Maria Chiara Brunese
Papers
2
Total Citations
39
H-Index
2
About
Maria Chiara Brunese is a leading surgical oncologist whose research focuses on optimizing treatment strategies for colorectal liver metastases (CRLM), particularly through the integration of advanced minimally invasive techniques. Her major contributions center on two critical areas: the management of synchronous colorectal liver metastases and the comparative effectiveness of robotic versus open liver surgery. In a landmark 2022 literature review encompassing 1,730 patients, she systematically analyzed outcomes for simultaneous resections of primary colorectal cancer and liver metastases, providing essential guidance for surgical decision-making in this complex patient population. This work has garnered 28 citations, reflecting its influence in shaping clinical practice. More recently, her 2024 multicenter study on a "Hub & Spoke" learning program demonstrated that robotic liver resection can achieve perioperative outcomes comparable to open surgery in high-volume referral centers, with 11 citations to date. Dr. Brunese’s research is notable for its rigorous propensity score matching methodology and its emphasis on real-world implementation of robotic programs. Her work directly addresses the pressing need for evidence-based guidelines in minimally invasive liver surgery, making her a pivotal voice in the ongoing evolution of hepatobiliary oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2